BioPharma Credit (BPCR)

$ 0.88
   
  • Change Today:
    $0.00
  • 52 Week High: $0.9
  • 52 Week Low: $0.8
  • Currency: US Dollars
  • Shares Issued: 1,228.08m
  • Volume: 1,605,131
  • Market Cap: $1,078.26m
  • RiskGrade: 32

Dividend Data

  31-Dec-2231-Dec-2131-Dec-2031-Dec-1931-Dec-18
1st Interim1.75¢1.75¢1.75¢1.75¢1.34¢
2nd Interim1.75¢1.75¢1.75¢1.75¢1.75¢
3rd Interim1.75¢1.75¢1.75¢1.75¢1.75¢
4th Interim1.75¢1.75¢1.75¢1.75¢1.75¢
Total Dividend7.00¢5.25¢7.00¢7.00¢6.59¢
For more dividend details, click here

Fundamentals

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19 31-Dec-18
Turnover 212.22 127.63 100.55 142.34 96.67
Operating Profit/(Loss) 176.39 108.73 79.67 113.82 73.63
Net Interest n/a n/a n/a n/a n/a
Profit Before Tax 176.39 108.73 79.67 113.82 69.95
Profit After Tax 176.39 108.73 79.67 113.82 69.95
Total Dividend Paid n/a n/a n/a n/a n/a
Retained Profit/(Loss) for the Financial Year 176.39 108.73 79.67 113.82 69.95
Earnings per Share - Basic 12.93¢ 7.91¢ 5.80¢ 8.28¢ 7.07¢
Earnings per Share - Diluted 12.93¢ 7.91¢ 5.80¢ 8.28¢ 7.07¢
Earnings per Share - Adjusted 12.93¢ 7.91¢ 5.80¢ 8.28¢ 7.07¢
Dividend per Share 7.00¢ 7.00¢ 7.00¢ 7.00¢ 6.94¢
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19 31-Dec-18
Fixed Assets          
Intangible Assets n/a n/a n/a n/a n/a
Tangible Assets n/a n/a n/a n/a n/a
Fixed Investments 1.22 1.27 1,194.83 1,116.13 1,008.25
  1.22 1.27 1,194.83 1,116.13 1,008.25
Current Assets          
Stocks n/a n/a n/a n/a n/a
Debtors 0.02 0.01 0.21 16.21 21.45
Cash at Bank & in Hand 0.12 0.09 193.27 296.64 363.57
Other Current Assets n/a n/a n/a n/a n/a
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 1.36 1.37 1,388.31 1,428.97 1,393.27
           
Liabilities          
Creditors: Amount Due Within 1 Year 0.03 0.01 9.39 24.50 5.46
Net Current Assets 0.11 0.09 184.08 288.34 379.56
           
Creditors: Amount Due Over 1 Year n/a n/a n/a n/a 7.79
Provisions for Liabilities & Charges n/a n/a n/a n/a n/a
Other Liabilities n/a n/a n/a 0.73 n/a
Total Liabilities 0.03 0.01 9.39 25.24 13.25
           
Net Assets 1.34 1.36 1,378.92 1,403.74 1,380.02
           
Capital & Reserves          
Called Up Share Capital 0.01 0.01 13.74 13.74 13.74
Share Premium Account 0.61 0.61 607.12 607.12 607.12
Other Reserves 0.67 0.72 750.51 741.18 736.35
Profit & Loss Account 0.04 0.02 7.55 41.69 22.80
Shareholders Funds 1.34 1.36 1,378.92 1,403.74 1,380.02
           
Minority Interests n/a n/a n/a n/a n/a
Capital Employed 1.34 1.36 1,378.92 1,403.74 1,380.02
Cash Flow 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19 31-Dec-18
Net Cash Flow From Operating Activities 0.18 0.10 58.07 131.52 67.14
Returns On Investment & Servicing of Finance n/a n/a n/a n/a n/a
Taxation Paid n/a n/a n/a n/a n/a
Capital Expenditure 0.05 (0.09) (47.47) (100.29) (436.99)
Acquisitions & Disposals n/a n/a n/a n/a n/a
Equity Dividends Paid (0.16) (0.10) n/a n/a n/a
Management of Liquid Resources n/a n/a n/a n/a n/a
Financing (0.05) n/a (113.96) (98.15) 382.64
Net Increase/Decrease In Cash 0.03 (0.10) (103.36) (66.92) 12.79
Ratios 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19 31-Dec-18
PE Ratio 7.3 12.2 17.2 12.3 15.1
PEG 0.1 0.3 n/a 0.7 0.2
EPS Growth 64% 36% -30% 17% 82%
Dividend Yield 7.4% 7.2% 7.0% 6.9% 6.5%
Dividend Cover 1.85 1.13 0.83 1.18 1.02
Dividend per Share Growth n/a n/a n/a 0.86% 131.33%
Operating Cashflow Per Share 0.015¢ 0.008¢ 4.73¢ 10.71¢ 5.47¢
Pre-tax Profit per Share 14.36¢ 0.089¢ 6.49¢ 9.27¢ 5.70¢
Cash Increase / Decrease per Share n/a n/a (8.42¢) (5.45¢) 1.04¢
Turnover per Share 17.28¢ 0.10¢ 8.19¢ 11.59¢ 7.87¢
Net Asset Value per Share 0.11¢ 0.11¢ 112.28¢ 114.30¢ 112.37¢
Operating Margin 83.12% 85.19% 79.23% 79.96% 76.16%
ROCE 13,188.73% 80.48% 5.78% 8.11% 5.07%
Net Gearing n/a n/a n/a n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page